• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2023     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Support for the implementation of new ways of working at the Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale]
2023     WorkSafeBC Cryoneurolysis for shoulder pain
2023     Ontario Health Carrier screening programs for cystic fibrosis, fragile X syndrome, hemoglobinopathies and thalassemia, and spinal muscular atrophy
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity
2023     Ontario Health Robotic-assisted partial nephrectomy for kidney cancer
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: innovations in home support, at the crossroads of humanity and technology]
2023     WorkSafeBC Creatine supplementation for treating concussions
2023     WorkSafeBC Glutamine for treating concussions
2023     WorkSafeBC Koebner phenomenon in connective tissue
2023     WorkSafeBC The effect of pepper spray on human health
2023     WorkSafeBC Myalgic encephalomyelitis/chronic fatigue syndrome associated with mRNA COVID-19 vaccination
2023     WorkSafeBC Platelet rich plasma as treatment for medial epicondylitis
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of Intercept and Mirasol - pathogen reduction technologies for the treatment of labile blood products in Quebec]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: principles and criteria guiding the use of parent-child trio genomewide sequencing in constitutional genetics - a report to support the work of the RQDM]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: urinary tract infection in people aged 14 and over - diagnostic guidelines, optimal use of 1st- and 2nd-line treatments and follow-up ]
2023     WorkSafeBC Low intensity pulsed ultrasound (LIPUS) for preventing fractures
2023     WorkSafeBC Efficacy of eye movement desensitization and reprocessing (EMDR) as treatment for major depression
2023     WorkSafeBC Firefighting and polycythemia vera
2023     WorkSafeBC HEPA filters and nanomaterials
2023     WorkSafeBC Hemorrhoids and heavy lifting
2023     WorkSafeBC Association between wearing orthosis and developing metatarsal stress fractures
2023     WorkSafeBC Causal association between firefighting and hypersensitivity pneumonitis
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [At a glance: screening and management algorithm management of precancerous lesions - cervical cancer and population-based screening]
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic drugs for severe asthma
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental polishing for oral health
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraocular lenses for cataract surgery
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Refractive laser surgery for vision conditions
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Buprenorphine naloxone film versus tablets for opioid use disorder
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Case carts in surgical settings
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti–vascular endothelial growth factor drugs for age-related macular degeneration
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care ultrasound for guided central venous catheter insertion
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) IV acetaminophen for acute pain in emergency departments
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Semaglutide 2 mg for type 2 diabetes
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Midline and extended dwell catheters for IV antibiotics
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Radiofrequency ablation for chronic knee, hip, and shoulder pain
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct-acting antivirals for pediatric chronic hepatitis C virus infection
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin for short stature
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-sterile glove use
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Early intervention programs for adolescents and young adults with eating disorders
2023     Ontario Health Bariatric surgery for adults with class I obesity and difficult-to-manage type 2 diabetes
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity: a health technology assessment
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency department overcrowding in Canada: an update
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: gene panel for the identification of myeloid mutations by NGS ‒ evaluation report on the repatriation of an analysis carried out outside of the province of Québec]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: resuscitation in community opioid overdose ‒ update and complement to INESSS guidance published in 2018 - Cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organizational models for the management of spinal cord injuries]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: benchmarks to improve services for at-risk or neglected children and their families]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid response: Cervical cancer: transition from from Pap test screening to HPV testing]
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of adult patients with chronic immune thrombocytopenia after failure of first-line therapies
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental bridges for partial tooth loss
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Optune - for the treatment of adult patients with newly diagnosed glioblastoma]
2023     WorkSafeBC Cold plunges as treatment for concussions
2023     WorkSafeBC Flotation therapy as treatment for concussions
2023     WorkSafeBC Efficacy of under-mask beard covers in quantitative fit testing of tight-fitting disposable respirators
2023     WorkSafeBC Causal association between COVID-19 infection and irritable larynx syndrome
2023     WorkSafeBC Migraines and the (Moderna) COVID-19 vaccine
2023     WorkSafeBC Botulinum toxin as treatment for neck strains
2023     WorkSafeBC Esketamine as treatment for depression and PTSD
2023     WorkSafeBC Platelet rich plasma in treating (recurrent) anterior shoulder dislocation
2023     WorkSafeBC Causal association between carpal tunnel release surgery and trigger finger
2023     WorkSafeBC Causal association between SARS-Cov-2 infection and the development of trigeminal neuralgia
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: models for coordinating interhospital transfers in critical care]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: asthma management in children and adults]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: implantable medical device tracking methods]
2023     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Speech-language therapy for laryngeal dysfunction]
2023     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Postoperative antimicrobial prophylaxis for thoracic surgery]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: use of healthcare services by people with confirmed SARS-CoV-2 infection and those with no documented evidence of infection]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: pediatric cancer predisposition using next-generation sequencing panels]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in psychiatry]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in respirology]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in pediatrics]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in neurology]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in internal medicine]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in hematology/oncology]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in general surgery]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual genes panels of pediatric cancers by NGS of somatic exome and transcriptome - evaluation report of an analysis developed by the RQDM]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: An overview of precision medicine initiatives here and elsewhere]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: overview of interventions addressed by some evaluation agencies outside Quebec - an exploration of the diversity of potential evaluation topics]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: rapid assessment zones in emergency departments - organizational characteristics and their impact]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: measurement and monitoring of total serum bilirubin in a newborn with signs suggestive of neonatal jaundice]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: developing portraits to support the ongoing adaptation of youth services by local service networks]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevant practices for promoting hearing health in long-term residential care settings]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Prolastin-C Liquid – congenital alpha1-antitrypsin deficiency]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Glassia – congenital alpha1- antitrypsin deficiency]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Zemaira - congenital alpha1- antitrypsin deficiency]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: acute exacerbation of chronic obstructive pulmonary disease -diagnostic approach, optimal use of treatments, and follow-up]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: evaluation and implementation of digital health solutions - a look at user participation]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: principles and criteria for gene selection for the molecular diagnosis of constitutional genetic diseases by next-generation sequencing - Report in support of the deployment of the sequencing service]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding the HbS/E, HbE/E and HbE/β-thal variants to the primary targets of the neonatal screening test for hemoglobinopathies]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: perineal and pelvic rehabilitation for the prevention and treatment of pelvic floor dysfunctions - Part 2: Anorectal dysfunction, pelvic organ prolapse and perineal pain in women]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: osseointegration of bone-anchored prostheses in individuals living with lower limb amputation(s)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: NGAL assay for the detection of acute kidney injury]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: NK cell degranulation (natural killer)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: impact of physical activity on the adverse effects of cancer and cancer treatments in adults]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: analysis of personal and clinical characteristics associated with a favourable response to psychosocial interventions aimed at preventing and treating common mental disorders and symptoms]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: Syphilis - detection, diagnosis, optimal antibiotic use, and follow-up]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: the management of myalgic encephalomyelitis / chronic fatigue syndrome]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of platelet-rich plasma for the treatment of knee osteoarthritis]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for for long-chain acyl-CoA dehydrogenase deficiency (LCHADD) and mitochondrial trifunctional protein deficiency (TFPD)]